What the agency says to do
FDA’s record gives no instruction for consumers.
Status: Ongoing. What the FDA’s recall statuses mean (opens in a new tab)
Note from Recalls Watch, not agency text
- Talk to your pharmacist or doctor before you stop taking a medicine. FDA: Medication Guides and your medicines (opens in a new tab)
- In an emergency call 911. For a possible poisoning call Poison Help at 1-800-222-1222. Poison Help (HRSA) (opens in a new tab)
- For refunds, repairs or replacements, follow the agency notice. Recalls.gov (opens in a new tab)
Why it was recalled
CGMP Deviations: Presence of N-nitroso-duloxetine impurity above the recommended interim limit.
FDA classification: Class II. What the FDA’s classes mean (opens in a new tab)
The recalled product
Codes in the record. Click one to copy it.
1 more codes are in the record below.
Duloxetine Delayed-Release Capsules USP, 30 mg, Rx only, 30 count bottles, Manufactured by: Aurobindo Pharma Limited, Hyderabad-500 090, India, For BluePoint Laboratories NDC 68001-414-04
- Lot or code
- Lot DT3023029A Exp 02/28/2025
- FDA recall number
- D-0155-2025
- Quantity
- 21,262 bottles
Duloxetine Delayed-Release Capsules, USP, 30 mg, Rx only, 90 count bottles, Manufactured by: Aurobindo Pharma Limited, Hyderabad-500 090, India, For BluePoint Laboratories NDC 68001-414-05
- Lot or code
- Lot DT3023030A Exp 2/28/2025
- FDA recall number
- D-0156-2025
- Quantity
- 13,678 bottles
Duloxetine Delayed-Release Capsules USP, 60 mg, Rx only, 30 count bottles, Manufactured by: Aurobindo Pharma Limited, Hyderabad-500 090, India, For BluePoint Laboratories NDC 68001-415-04
- Lot or code
- Lot DT6023061B Exp 01/31/2025
- FDA recall number
- D-0157-2025
- Quantity
- 20,734 30-count bottles
Duloxetine Delayed-Release Capsules, USP, 60 mg, Rx only, 1,000 count bottles, Manufactured by: Aurobindo Pharma Limited, Hyderabad-500 090, India, For BluePoint Laboratories NDC 68001-415-08
- Lot or code
- Lots, expiry: Lot DT6022166A, exp 11/30/2024; Lot DT6023071A, exp 2/28/2025
- FDA recall number
- D-0158-2025
- Quantity
- 1,815 bottles
Distribution (FDA): Nationwide in the USA
Source
- Issued by
- U.S. Food and Drug Administration
- Firm
- Amerisource Health Services LLC
- Title
- Composed by Recalls Watch from fields of the record; FDA records have no title.